Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

9 METERS BIOPHARMA, INC. (INNT)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues  0.00.00.00.00.00.04.18.3
            Revenue growth       -100.0%-50.8%-27.1%
Cost of goods sold  0.00.00.00.00.00.03.37.8
Gross profit  0.00.00.00.00.00.00.70.4
            Gross margin        18.1%5.2%
Selling, general and administrative   [+]11.09.710.510.610.77.26.46.6
Research and development  31.022.010.913.77.64.00.30.3
Other operating expenses  -0.4 7.21.3    
EBITDA   [+]-41.6-31.7-28.6-25.5-18.2-11.2  
            EBITDA margin        -143.0%-77.5%
Depreciation  0.00.00.00.00.00.0  
EBITA  -41.6-31.7-28.6-25.5-18.2-11.2-5.8-6.4
            EBITA margin        -143.0%-77.5%
Amortization of intangibles        0.10.1
EBIT   [+]-41.6-31.7-28.6-25.5-18.2-11.2-5.9-6.5
            EBIT margin        -146.2%-78.2%
Non-recurring items   [+]0.45.132.3     
Interest expense, net   [+]2.20.04.01.66.00.40.81.4
Other income (expense), net   [+]0.40.03.40.10.0 0.6-0.9
Pre-tax income  -43.8-36.8-61.5-27.0-24.2-11.6-6.2-8.7
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%  
Net income  -43.8-36.8-61.5-27.0-24.2-11.6-6.2-8.7
            Net margin        -152.8%-105.7%
   
Basic EPS   [+]($3.38)($3.03)($0.58)($0.81)($0.98)($0.98)($11.26)($2.65)
Diluted EPS   [+]($3.38)($3.03)($0.58)($0.81)($0.98)($0.98)($11.26)($2.65)
   
Shares outstanding (basic)   [+]13.012.2105.633.324.811.90.63.3
Shares outstanding (diluted)   [+]13.012.2105.633.324.811.90.63.3
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy